Product Information
MT-802 is a small molecule that inhibits the ubiquitin-proteasome system. It has been shown to inhibit tumor xenografts and chronic lymphocytic leukemia in animal models. MT-802 molecule has also shown efficacy in treating autoimmune diseases, such as lupus. The drug works as a covalent inhibitor of polyubiquitin, which is involved in the process of protein degradation by proteasomes. MT-802 binds to polyubiquitin and irreversibly inhibits its function, leading to increased degradation of proteins and inhibition of tumor growth.
Chemical properties
Technical inquiry about: 3D-GPD74429 MT-802
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
